精东影业

News

Demonstrating Excellence in Outcomes and Culture

Onco360庐 Has Been Selected as The National Specialty Pharmacy Partner for Tevimbra庐 (tislelizumab-jsgr)

Home / News / Specialty Pharmacy / Page 3

Specialty Pharmacy | News

Stay up to date with the latest innovations, company updates, and industry insights as we work to advance health and wellness for all.

Onco360庐 Has Been Selected as The National Specialty Pharmacy Partner for Tevimbra庐 (tislelizumab-jsgr)

Three logos featured: Onco360, Rybrevant, Lazcluze

LAZCLUZE鈩� (lazertinib) Now Available from Onco360

Onco360庐 Has Been Selected as a National Specialty Pharmacy Partner for VORANIGO庐

Onco360 - Rytelo

Onco360 Selected as a Limited Distribution Specialty Pharmacy Partner for Rytelo鈩� (imetelstat)

Onco360 Chief Commercial Officer Named 40 Under 40 in Cancer

OJEMDA™ (tovorafenib) Now Available from Onco360 for the Treatment of Patients Six Months of Age and Older with Relapsed or Refractory Pediatric Low-Grade Glioma (LGG) Harboring a BRAF Fusion or Rearrangement, or BRAF V600 Mutation

WHAT PEOPLE ARE SAYING